VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 100 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $36,211,000 | +36.8% | 2,270,297 | +42.7% | 0.01% | +40.0% |
Q3 2016 | $26,476,000 | +56.0% | 1,591,102 | +4.9% | 0.01% | +25.0% |
Q2 2016 | $16,975,000 | +23.7% | 1,517,007 | -7.6% | 0.00% | +33.3% |
Q1 2016 | $13,728,000 | -9.1% | 1,642,070 | +1.2% | 0.00% | 0.0% |
Q4 2015 | $15,109,000 | -20.5% | 1,622,846 | -3.7% | 0.00% | -40.0% |
Q3 2015 | $19,004,000 | -8.8% | 1,684,784 | +2.6% | 0.01% | 0.0% |
Q2 2015 | $20,833,000 | +50.8% | 1,641,711 | +10.5% | 0.01% | +66.7% |
Q1 2015 | $13,812,000 | -37.9% | 1,485,191 | -4.4% | 0.00% | -40.0% |
Q4 2014 | $22,243,000 | +74.3% | 1,553,289 | +26.3% | 0.01% | +25.0% |
Q3 2014 | $12,763,000 | -36.6% | 1,229,530 | -1.2% | 0.00% | -33.3% |
Q2 2014 | $20,133,000 | -7.3% | 1,244,343 | -6.9% | 0.01% | 0.0% |
Q1 2014 | $21,711,000 | +36.8% | 1,336,039 | +4.5% | 0.01% | +20.0% |
Q4 2013 | $15,873,000 | +11.5% | 1,279,081 | -1.6% | 0.01% | 0.0% |
Q3 2013 | $14,236,000 | +81.9% | 1,300,131 | +34.2% | 0.01% | +66.7% |
Q2 2013 | $7,825,000 | – | 968,501 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |